Status:
ENROLLING_BY_INVITATION
Automated V Manual Impactor Study
Lead Sponsor:
Rothman Institute Orthopaedics
Collaborating Sponsors:
UCLA Health - Santa Monica Medical Center
University of Virginia
Conditions:
Total Hip Arthroplasty (THA)
Impaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates the use of an automated impactor device in total hip arthroplasty versus manual malleting method and the physiological strain on the surgeon. This study will be a randomized, p...
Eligibility Criteria
Inclusion
- Patients undergoing primary elective THAs Participants over the age of 18 Patients with compatible implants
Exclusion
- Attending orthopaedic surgeons with pre-existing cardiorespiratory or musculoskeletal conditions Use of cemented or hybrid THA Patients undergoing a conversion or revision THA Patients undergoing a non-elective THA (i.e., for fracture) Participants lacking cognitive capacity to consent Participants who are pregnant
Key Trial Info
Start Date :
March 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06903767
Start Date
March 25 2025
End Date
March 31 2026
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107